Sickle Cell Disease Treatment Centers Act of 2022

Summary

Sickle Cell Disease Treatment Centers Act of 2022 This bill directs the Department of Health and Human Services to award grants for establishing sickle cell disease treatment centers that operate using a hub-and-spoke framework to provide integrated, longitudinal health care for patients with the disease and individuals with sickle cell trait. Grant recipients must be networks comprised of (1) a hospital, clinic, or university health center; (2) at least one federally qualified health center or other health care organization that incorporates community health workers into the care team; and (3) at least one community-based organization. Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 15 September 2022

   Introduced

   Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

   Source: IntroReferral

2. 15 September 2022

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 15 September 2022 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 15 September 2022

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 15 September 2022

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 15 September 2022

  Open at official source

Sponsors

• Chris Van Hollen · D · Sponsor
• Sen. Booker, Cory A. [D-NJ] · D · Sponsor
• · sshr00 · Standing

Related records

• related to ← Sickle Cell Disease Treatment Centers Act of 2022
• related to ← Minority Fellowship Program Reauthorization Act of 2022